Water-soluble triazapyridinophane-based complexing agents and corresponding fluorescent lanthanide complexes

US2018362549A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018362549-A1
Application numberUS-201616060291-A
CountryUS
Kind codeA1
Filing dateDec 9, 2016
Priority dateDec 9, 2015
Publication dateDec 20, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to complexing agents of formula (I) in which A 1 , A 2 , A 3 and R 1 are as defined in the description. The invention also relates to lanthanide complexes obtained from said complexing agents. The invention can be used for marking biological molecules.

First claim

Opening claim text (preview).

1 . A complexing agent of formula (I): wherein: the R 1 groups are identical and are either: —CO 2 H, or —PO(OH)R, wherein R is selected from the group consisting of: phenyl optionally substituted by an —SO 3 H group benzyl, methyl, ethyl, propyl, n-butyl, sec-butyl, isobutyl, and tert-butyl; the A 1 , A 2 groups are identical or different and are selected from the group consisting of: a group of formula -L 1 -E; a group of formula (II) and a group of formula (II′); the A 3 group is selected from the group consisting of: a group of formula —O-L 3 -G, a group of formula (II), a group of formula (II′), a group of formula and a group of formula (III′); L 1 , L 2 and L 3 are identical or different and each represent a divalent linkage group; E is a group that renders the complexing agent water-soluble, chosen selected from the group consisting of: —SO 3 H, —PO(OH) 2 , —CO 2 H, —N + Alk 1 Alk 2 Alk 3 , a carbohydrate residue, a sulfobetaine; and a PEG group; G is a reactive group; Alk 1 , Alk 2 , Alk 3 , which may be identical or different, each represent a (C 1 -C 6 )alkyl. 2 . The complexing agent as claimed in claim 1 , wherein A 1 and A 2 are identical and are a group of formula (II) and A 3 is a group of formula (III). 3 . The complexing agent as claimed in claim 1 , wherein A 1 is a group of formula (II), A 2 is an -L 1 -E group and A 3 is a group of formula (III). 4 . The complexing agent as claimed in claim 1 , wherein A 1 and A 2 are identical and are groups of formula (II), and A 3 is a group of formula —O-L 3 -G. 5 . The complexing agent as claimed in claim 1 , wherein A 1 and A 2 are identical and are groups of formula -L 1 -E and A 3 is a group of formula (III). 6 . The complexing agent as claimed in claim 1 , wherein A 1 and A 2 are identical and are groups of formula (II′) and A 3 is a group of formula (III′). 7 . The complexing agent as claimed in claim 1 , wherein A 1 is a group of formula (II′), A 2 is an -L 1 -E group and A 3 is a group of formula (III′). 8 . The complexing agent as claimed in claim 1 , wherein A 1 and A 2 are identical and are groups of formula (II′), and A 3 is a group of formula —O-L 3 -G. 9 . The complexing agent as claimed in claim 1 , wherein A 1 and A 2 are identical and are groups of formula -L 1 -E and A 3 is a group of formula (III′). 10 . The complexing agent as claimed in claim 1 , wherein the reactive group G is selected from the group consisting of: an acrylamide, an amine, an ester, an aldehyde, an alkyl halide, an anhydride, an aniline, an azide, an aziridine, a carboxylic acid, a diazoalkane, a haloacetamide, a halotriazine, dichlorotriazine, a hydrazine, an imido ester, an isocyanate, an isothiocyanate, a maleimide, a sulfonyl halide, a thiol, a ketone, an acid halide, a succinimidyl ester, a hydroxysuccinimidyl ester, a hydroxysulfosuccinimidyl ester, an azidonitrophenyl, an azidophenyl, a glyoxal, a triazine, and an acetylenic group. 11 . The complexing agent as claimed in claim 1 , wherein the spacer arms L 1 , L 2 and L 3 , when they are present, are selected from the group consisting of: a linear or branched C 1 -C 20 alkylene group optionally containing one or more double or triple bonds; a C 5 -C 8 cycloalkylene group, a C 6 -C 14 arylene group, said alkylene, cycloalkylene or arylene groups optionally containing one or more hetero atoms, or one or more carbamoyl or carboxamido groups, and said alkylene, cycloalkylene or arylene groups being optionally substituted by C 1 -C 8 alkyl, C 6 -C 14 aryl, sulfonate or oxo groups; and a group having one of the following formulae: wherein n, m, p, q are integers from 1 to 5. 12 . The complexing agent as claimed in claim 1 , wherein the -L 3 -G group, consists of (i) a reactive group G selected from the group consisting of: a carboxylic acid, an amine, a succinimidyl ester, a haloacetamide, a hydrazine, an isothiocyanate, and a maleimide group, and (ii) a spacer arm L 3 consisting of an alkylene group comprising from 1 to 5 carbon atoms. 13 . The complexing agent as claimed in claim 1 , wherein L 1 is a divalent group of formula: where n is an integer from 1 to 5. 14 . The complexing agent as claimed in claim 1 , wherein L 2 is a divalent group of formula: where n and m are integers 1 to 5. 15 . The complexing agent as claimed in claim 1 , wherein L 3 is a divalent group of formula: —(CH 2 ) n — where n is an integer from from 1 to 5. 16 . A fluorescent lanthanide complex comprising a complexing agent as claimed in claim 1 and a lanthanide selected from the group consisting of: Eu 3+ , Sm 3+ , and Tb 3+ . 17 . A fluorescent lanthanide complex of formula (IV), (V), (VI) or (VII) below: wherein: Ln 3+ is chosen from: Eu 3+ , Tb 3+ , Sm 3+ ; R 3 is chosen from the following groups: OH; 18 . A fluorescent conjugate of a molecule of interest, wherein said conjugate is obtained by bringing a lanthanide complex as claimed in claim 16 , said complex comprising a reactive group G, into contact with said molecule of interest. 19 . The complexing agent as claimed in claim 10 , wherein the reactive group G is a group having one of the following formulae: wherein w varies from 0 to 8 and v is equal to 0 or 1, and Ar is a saturated or unsaturated 5- or 6-membered heterocycle, comprising 1 to 3 heteroatoms, optionally substituted by a halogen atom.

Assignees

Inventors

Classifications

  • C07F5/003Primary

    without C-Metal linkages · CPC title

  • with fluorescent label · CPC title

  • containing three or more hetero rings · CPC title

  • Rare earth chelates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018362549A1 cover?
The invention relates to complexing agents of formula (I) in which A 1 , A 2 , A 3 and R 1 are as defined in the description. The invention also relates to lanthanide complexes obtained from said complexing agents. The invention can be used for marking biological molecules.
Who is the assignee on this patent?
Cisbio Bioassays, Univ Toulouse, Centre Nat Rech Scient
What technology area does this patent fall under?
Primary CPC classification C07F5/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).